Evaluating Modern Spacer Options and Outcomes in Revision Hip Arthroplasty.

Autor: Tseng J; Department of Orthopedic Surgery, Rush University Medical Center, Chicago, Illinois., Oladipo VA; Department of Orthopedic Surgery, Rush University Medical Center, Chicago, Illinois., Acuña AJ; Department of Orthopedic Surgery, Rush University Medical Center, Chicago, Illinois., Jones CM; Department of Orthopedic Surgery, Rush University Medical Center, Chicago, Illinois., Tsintolas J; Department of Orthopedic Surgery, Rush University Medical Center, Chicago, Illinois., Levine BR; Department of Orthopedic Surgery, Rush University Medical Center, Chicago, Illinois.
Jazyk: angličtina
Zdroj: The Journal of arthroplasty [J Arthroplasty] 2024 Sep; Vol. 39 (9S1), pp. S236-S242. Date of Electronic Publication: 2024 May 14.
DOI: 10.1016/j.arth.2024.05.017
Abstrakt: Background: A 2-stage revision continues to be the standard treatment for periprosthetic joint infection (PJI) in hip arthroplasty. The use of "functional" spacers may allow patients to return to daily living while optimizing their health for revision surgery. We aimed to evaluate the clinical outcomes of different spacer types regarding infection eradication, mechanical complications, and functional outcomes.
Methods: Patients who have complete Musculoskeletal Infection Society criteria for diagnosis of PJI that underwent one-stage or 2-stage revision were queried in an institutional surgical database between 2002 and 2022. Out of 286 patients, 210 met our inclusion criteria and were retrospectively reviewed for demographics, laboratory values, functional and patient-reported outcomes, and subsequent revisions. The study population had 54.3% women, a mean age of 61 years old, and a mean follow-up of 3.7 ± 3.2 years. There was no difference between age, body mass index, or Charlson Comorbidity Index scores between each cohort. Spacers were categorized as nonfunctional static, nonfunctional articulating, or functional articulating. Functional spacers were defined as those that allowed full weight bearing with no restrictions. Delphi criteria were used to define revision success, and failure was defined as a recurrent or persistent infection following definitive surgery.
Results: There was a significantly lower reoperation rate after a definitive implant in the functional articulating cohort (P = .003), with a trending higher infection eradication rate and a lower rate of spacer failure compared to the nonfunctional spacer cohort. At 5 years, functional articulating spacers had a 94.1% survivorship rate, nonfunctional articulating spacers had an 81.2% survival rate, and nonfunctional static spacers had a 71.4% survival rate. In the functional articulating spacer cohort, 14.6% had yet to get reimplanted, with an average follow-up time of 1.4 years.
Conclusions: Within this large cohort of similar demographics, functional articulating spacers may result in better clinical outcomes and infection eradication during 2-stage revision arthroplasty for PJI.
(Copyright © 2024 Elsevier Inc. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: